Search research articles
Contact Us
Filters
Showing results (591-600 of 602) with videos related to
Page
of 61
Sort By:
Haematologica
|
September 28, 2019
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study
Francesco Paciullo, Loredana Bury, Patrizia Noris, et al.
Biochemical Pharmacology
|
January 2, 2026
Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy
Daniel J de Klerk, Mark J de Keijzer, Leonardo P Franchi, et al.
Arthritis Care & Research
|
July 7, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions
Medha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, et al.
Arthritis Care & Research
|
August 13, 2024
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis
Medha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 18, 2023
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology
Marie-Christine Alessi, Carmen Coxon, Manal Ibrahim-Kosta, et al.
Autoimmunity Reviews
|
April 3, 2020
In utero exposure to Azathioprine in autoimmune disease. Where do we stand?
Cristina Belizna, Pier Luigi Meroni, Yehuda Shoenfeld, et al.
BMC Genomics
|
February 1, 2014
Finding the missing honey bee genes: lessons learned from a genome upgrade
Christine G Elsik, Kim C Worley, Anna K Bennett, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
Medha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases
|
August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Medha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Autoimmunity Reviews
|
October 15, 2018
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome
Cristina Belizna, Francesca Pregnolato, Sebastien Abad, et al.
Page
of 61
Search research articles
Search
Showing results (591-600 of 602) with videos related to
Sort By:
Page
of 61
Haematologica
|
September 28, 2019
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study
Francesco Paciullo, Loredana Bury, Patrizia Noris, et al.
Biochemical Pharmacology
|
January 2, 2026
Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy
Daniel J de Klerk, Mark J de Keijzer, Leonardo P Franchi, et al.
Arthritis Care & Research
|
July 7, 2025
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions
Medha Barbhaiya, Stephane Zuily, Deanna Jannat-Khah, et al.
Arthritis Care & Research
|
August 13, 2024
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis
Medha Barbhaiya, Stephane Zuily, Mary-Carmen Amigo, et al.
Journal of Thrombosis and Haemostasis : JTH
|
June 18, 2023
Multicenter evaluation of light transmission platelet aggregation reagents: communication from the ISTH SSC Subcommittee on Platelet Physiology
Marie-Christine Alessi, Carmen Coxon, Manal Ibrahim-Kosta, et al.
Autoimmunity Reviews
|
April 3, 2020
In utero exposure to Azathioprine in autoimmune disease. Where do we stand?
Cristina Belizna, Pier Luigi Meroni, Yehuda Shoenfeld, et al.
BMC Genomics
|
February 1, 2014
Finding the missing honey bee genes: lessons learned from a genome upgrade
Christine G Elsik, Kim C Worley, Anna K Bennett, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
August 28, 2023
The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria
Medha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Annals of the Rheumatic Diseases
|
August 28, 2023
2023 ACR/EULAR antiphospholipid syndrome classification criteria
Medha Barbhaiya, Stephane Zuily, Ray Naden, et al.
Autoimmunity Reviews
|
October 15, 2018
HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome
Cristina Belizna, Francesca Pregnolato, Sebastien Abad, et al.
Page
of 61